Lake Forest Park, WA, United States of America

Daniel S Allison

USPTO Granted Patents = 31 (Patent Applications = 8)

EPO Patents = 5 (Patent Applications = 17)

Average Co-Inventor Count = 12.1

ph-index = 5

Forward Citations = 65(Granted Patents)

Location History:

Lake Forrest Park, WA (US) (2019)
Lake Forest Park, WA (US) (2013 - 2024)

Company Filing History:

Alderbio Holdings LLC

patents

4. 4 out of 8

Alder Biopharmaceuticals, Inc.

patents

5. 3 out of 903

University of Iowa Research Foundation

patents

6. 1 out of 2,103

University of Washington

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428475 - Humanized anti-ACTH antibodies and use thereof (2025-09-30),

2. 12351627 - Anti-ACTH antibodies and use thereof (2025-07-08),

3. 12162936 - Methods of treatment with anti-PACAP antibodies (2024-12-10),

4. 12077581 - Anti-PACAP antibodies and uses thereof (2024-09-03),

5. 11993648 - Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion (2024-05-28),

6. 11938185 - Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies (2024-03-26),

7. 11427631 - Anti-ACTH antibodies and use thereof (2022-08-30),

8. 11352409 - Anti-PACAP antibodies and uses thereof (2022-06-07),

9. 11254741 - Anti-PACAP antibodies (2022-02-22),

10. 11117960 - Humanized anti-ACTH antibodies and use thereof (2021-09-14),

11. 10981985 - Anti-PACAP antibodies (2021-04-20),

12. 10981984 - Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion (2021-04-20),

13. 10975135 - Humanized anti-PACAP antibodies (2021-04-13),

14. 10968268 - Humanized anti-PACAP antibodies (2021-04-06),

15. 10954285 - Humanized anti-PACAP antibodies (2021-03-23),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will be happy to provide you with an article about inventor Daniel S Allison.

**Title: The Inventor Profile: Daniel S Allison**

Introduction:

Daniel S Allison, a prolific inventor based in Lake Forest Park, WA (US), has made significant contributions to the field with a total of 26 patents under his name. His innovative work focuses on developing treatments for various conditions using cutting-edge antibody technologies.

Latest Patents:

Among his recent patents is the groundbreaking "Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies." This invention revolves around antibodies with binding specificity for PACAP, targeting conditions related to vasodilation, photophobia, and neuronal activation. Another notable patent is "Anti-ACTH antibodies and use thereof," which highlights his research on ACTH-related diseases such as Cushing's Syndrome, Parkinson's disease, and diabetes.

Career Highlights:

Daniel S Allison has worked with renowned companies like H. Lundbeck A/S and Omeros Corporation, where he has undoubtedly honed his skills and expertise in the field of biotechnology and pharmaceuticals. His journey is marked by a relentless pursuit of innovative solutions to complex medical problems.

Collaborations:

Throughout his career, Daniel S Allison has collaborated closely with industry experts such as John A Latham and Leon F Garcia-Martinez. These collaborations have been instrumental in the development and implementation of his patented inventions, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion:

In conclusion, Daniel S Allison's impressive portfolio of patents reflects his dedication to advancing healthcare through innovative antibody-based therapies. His collaborations with top-tier professionals and his tenure at prominent companies underscore his impact on the biotechnology landscape. As a visionary inventor, Daniel S Allison continues to push the boundaries of science and medicine, leaving a lasting legacy in the field of therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.